Intralesional interferon-alpha 2b treatment of basal cell carcinoma.
DOI:
https://doi.org/10.2340/00015555-70512514Abstract
Ten patients with histologically proven basal cell carcinoma were treated with sublesional injections of interferon-alpha 2 b (Introna), 1.5 x 10(6) units per injection, three times per week for 3 weeks. Six of the treated lesions cleared completely without further therapy. These lesions measured less than 19 x 19 mm. There was no relapse during an observation period of up to 21 months. Non-healing tumours were large (greater than 20 x 20 mm) and two of them were of nodular type. Side effects were negligible, if present at all. Introna seems to offer a valuable alternative treatment for selected cases of basal cell carcinoma, when excision or X-ray therapy cannot be performed.Downloads
Download data is not yet available.
Downloads
Published
1990-11-01
How to Cite
Thestrup-Pedersen, K., Jacobsen, I. E., & Frentz, G. (1990). Intralesional interferon-alpha 2b treatment of basal cell carcinoma. Acta Dermato-Venereologica, 70(6), 512–514. https://doi.org/10.2340/00015555-70512514
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
